academic article

• A novel HSP90 inhibitor-drug conjugate to SN38 is highly effective in small cell lung cancer (SCLC)..  Clinical cancer research : an official journal of the American Association for Cancer Research.  :-. 2016
• Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis. 2016